natgillin/translations-raw huggingface dataset:
It is not yet fully established whether immunocompetent individuals who have responded to hepatitis A vaccination will require booster doses as protection in the absence of detectable antibodies may be ensured by immunological memory. 
Potreba po obnovitvenih odmerkih pri imunokompetentnih osebah, ki so se odzvale na cepljenje proti hepatitisu A, še ni popolnoma dokazana, ker je lahko zaščita v odsotnosti dokazljivih protiteles zagotovljena z imunskim spominom.
• This vaccine has been prescribed for you/your child only. 
• Cepivo je bilo predpisano vam/vašemu otroku in ga ne smete dajati drugim.
• Ambirix helps the body to produce its own protection (antibodies) against these diseases. 
Kako deluje cepivo Ambirix • Cepivo Ambirix telesu pomaga, da proizvede lastno zaščito (protitelesa) proti tema boleznima.
Tell your doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment: 
V primeru, da opazite katerega koli od spodaj naštetih resnih neželenih učinkov, se nemudoma posvetujte z zdravnikom - lahko da boste potrebovali nujno medicinsko pomoč:
• purple or reddish-purple bumps on the skin (lichen planus), serious skin rashes (erythema multiforme) 
• vijoličaste ali rdeče vijoličaste bunčice na koži (lichen planus), resna oblika izpuščaja na koži (multiformni eritem),
The vaccine has not been tested in patients with an impaired immune system. 
Pri bolnikih z oslabljenim imunskim sistemom cepivo ni bilo preizkušeno.
Read all of this leaflet carefully before you/your child starts receiving this vaccine because it contains important information for you. 
Pred začetkom uporabe zdravila natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Read the package leaflet before use Intramuscular use Shake well before use 
Intramuskularna uporaba Pred uporabo dobro pretresite
For some categories of subjects at risk of exposure to HBV (e.g. haemodialysis or immunocompromised patients) a precautionary attitude should be considered to ensure that a protective antibody level ≥ 10 mIU/ml is maintained. 
Pri nekaterih skupinah oseb s tveganjem za okužbo s HBV (npr. bolniki na hemodializi ali bolniki z oslabljenim imunskim sistemom) je, da bi se zaščitni titer protiteles ≥ 10 i.e./l ohranil, treba upoštevati previdnostne ukrepe.
6.4 Special precautions for storage Store in a refrigerator (2°C - 8°C). 
Shranjujte v hladilniku (2 °C - 8 °C).
- It is recommended that Ambirix should be administered in settings where completion of the two-dose vaccination course can be assured. 
- Ambirix je priporočljivo dajati v okoliščinah, ki zagotavljajo dokončanje cepljenja z dvema odmerkoma.
Very rare: urticaria 
Zelo redki: urtikarija.
The recommended schedule should be adhered to. Once initiated, the primary course of vaccination should be completed with the same vaccine. 
Pričeto osnovno cepljenje je treba dokončati z istim cepivom.
Non-clinical data reveal no special hazard for humans based on general safety studies. 
5.3 Predklinični podatki o varnosti Predklinični podatki na osnovi običajnih študij varnosti ne kažejo posebnega tveganja za človeka.
Ambirix may need to be given at the same time as other vaccines for measles, mumps, rubella, diphtheria, tetanus, whooping cough (pertussis), poliomyelitis, Haemophilus influenzae type b or some types of treatments for hepatitis infections called “immunoglobulins”. 
Cepivo Ambirix bo morda potrebno dati hkrati z drugimi cepivi proti ošpicam, mumpsu, rdečkam, davici, tetanusu, oslovskemu kašlju (pertusis), otroški paralizi, Haemophilusu influenzae tipa b ali nekaterim tipom zdravil za zdravljenje okužb s hepatitisom, imenovanih »imunoglobulini«.
The following adverse reactions were reported during post-marketing surveillance following vaccination with Ambirix. 
Naslednje neželene učinke so zabeležili med postmarketinškim spremljanjem po cepljenju s cepivom
The most commonly reported adverse reactions following Ambirix administration are pain and fatigue occurring in an approximated per dose frequency of 50% and 30% respectively. 
Najbolj pogosta neželena učinka, o katerih so poročali po uporabi cepiva Ambirix, sta bolečina in utrujenost, ki se pojavita s približno pogostnostjo na odmerek v 50 % prvi oziroma 30 % drugi neželeni učinek.
• Hepatitis B: Infection with the hepatitis B virus may cause the liver to become swollen (inflamed). 
• Hepatitis B: Okužba z virusom hepatitisa B lahko povzroči oteklino jeter (vnetje).
• a degenerative disease of the brain (encephalopathy) 
• degenerativna možganska bolezen (encefalopatija),
In situations where a booster dose of hepatitis A and/or hepatitis B is desired, a monovalent or combined vaccine can be given. 
V okoliščinah, ko je zaželen obnovitveni odmerek cepiva proti hepatitisu A in/ali hepatitisu B, se lahko cepi z monovalentnim ali s kombiniranim cepivom.
In 2 comparative trials in subjects aged 1-15 years, the incidences of local and general solicited symptoms after a two dose regimen of Ambirix was overall similar to that seen with the three dose combined vaccine containing 360 ELISA Units of HAV and 10 µg of HBsAg. 
V 2 primerjalnih preskušanjih pri otrocih, starih od 1 do 15 let, so bile incidence lokalnih in splošnih nespontano evidentiranih simptomov po shemi z dvema odmerkoma cepiva Ambirix v celoti podobne kot po uporabi treh odmerkov kombiniranega cepiva, ki je vsebovalo 360 ELISA-enot HAV in 10 µg HBsAg.
- Hepatitis A virus (inactivated) 1,2 
-Virus hepatitisa A (inaktivirani)1,2
Rare: arthralgia 
Redki: artralgija.
• paralysis, drooping eyelid and sagging muscles on one side of the face (facial palsy) 
• paraliza, spuščena veka in mlahave mišice na eni strani obraza (paraliza obraza),
However, it is sometimes caught in other ways, such as by swimming in water that has sewage in it or from another infected person. 
Do okužbe običajno pride s hrano ali pijačo, ki vsebuje virus, lahko pa se prenaša tudi na druge načine, na primer s plavanjem v vodi, ki je onesnažena s fekalijami ali preko okužene osebe.
INFORMATION IN BRAILLE Justification for not including Braille accepted. 
Sprejeta je utemeljitev, da Braillova pisava ni potrebna
• If you have any further questions, ask your doctor, nurse or pharmacist. 
• Če imate dodatna vprašanja, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
Immune system disorders Allergic reactions including mimicking serum sickness, angioneurotic oedema 
Alergijske reakcije, vključno s takšnimi, ki so podobne serumski bolezni, angionevrotični edem.
Ambirix should only be used during breast-feeding when the possible advantages outweigh the potential risks. 
Cepivo Ambirix se sme med obdobjem dojenja uporabiti le, če možne koristi odtehtajo možna tveganja.
1 dose (1 ml) 
1 odmerek (1 ml)
In haemodialysis patients and persons with an impaired immune system, adequate anti-HAV and anti-HBs antibody titers may not be obtained after the primary immunisation course. 
Pri bolnikih na hemodializi in osebah z oslabljenim imunskim sistemom je možno, da po zaključku osnovnega cepljenja niso doseženi primerni titri protiteles anti-HAV in anti-HBs.
The percentages with anti-HBs antibody ≥10 mIU/ml at this time point for subjects aged 1-11 years or 12-15 years at the time of the first dose were 77.3% and 85.9%, respectively. 
Delež protiteles anti-HBs ≥10 mi.e./ml je bil pri osebah, starih ob prvem cepljenju od 1 do 11 let ali 12 do 15 let, ob tem času 77,3 % pri prvih in 85,9 % pri drugih.
• generally feeling unwell 
• splošno slabo počutje,
EXPIRY DATE EXP: MM/YYYY 
EXP: MM/LLLL
What Ambirix looks like and contents of the pack 
Izgled cepiva Ambirix in vsebina pakiranja
Adverse reactions reported following overdosage were similar to those reported with normal vaccine administration. 
opisani po prevelikem odmerjanju, so bili podobni kot po normalni uporabi cepiva.
The safety and immunogenicity of Ambirix administered as a booster dose following a two dose primary course have not been evaluated. 
Varnost in imunogenost obnovitvenega odmerka cepiva Ambirix, danega po že prejetih dveh odmerkih v času osnovnega cepljenja, nista bili ovrednoteni.
- Hepatitis B surface antigen 3,4 
-Površinski antigen virusa hepatitisa B3,4
They are called hepatitis B “carriers” and can still infect other people throughout their lives. 
Imenujejo se klicenosci virusa hepatitisa B in lahko ves čas življenja prenašajo virus hepatitisa B na druge.
As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reactions following the administration of the vaccine. 
Tako kot pri vseh cepivih za injiciranje je zaradi možnih redkih primerov anafilaktične reakcije po aplikaciji treba vedno razpolagati s takojšnjim ustreznim zdravljenjem in nadzorom.
However, when the monovalent hepatitis A and hepatitis B vaccines were administered concomitantly with specific immunoglobulins there was no effect on seroconversion rates. 
Kljub temu pa sočasno dajanje monovalentnih cepiv proti hepatitisu A in hepatitisu B ter specifičnih imunoglobulinov ni vplivalo na odstotek serokonverzije.
The holder of marketing authorisation will continue to submit annual PSURs. 
C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM Imetnik dovoljenja za promet z zdravilom bo periodična poročila o varnosti zdravila (PSUR) še naprej predajal letno.
Ambirix confers immunity against HAV and HBV infection by inducing specific anti-HAV and antiHBs antibodies. 
Mehanizem delovanja Ambirix zagotavlja imunost proti okužbi s HAV in HBV tako, da inducira tvorbo specifičnih anti
In both studies, subjects received either a two dose schedule of Ambirix or a three dose regimen of the combined vaccine containing 360 ELISA Units of formalin inactivated hepatitis A virus and 10 micrograms of recombinant hepatitis B surface antigen. 
V obeh študijah so osebe prejele bodisi cepivo Ambirix po shemi dveh odmerkov bodisi tri odmerke kombiniranega cepiva z vsebnostjo 360 ELISA enot s formalinom inaktiviranega virusa hepatitisa A in 10 mikrogramov rekombinantnega površinskega antigena virusa hepatitisa B.
In clinical studies involving subjects from 1 year up to and including 15 years old, seropositivity rates for anti-HAV antibodies were 99.1% one month after the first dose and 100% after the second dose given at month 6 (i.e month 7). 
V kliničnih študijah, v katere so bile vključene osebe, stare od 1 do vključno 15 let, je bil en mesec po prejemu prvega odmerka odstotek seropozitivnosti za protitelesa anti-HAV 99,1 %, po prejemu drugega odmerka čez 6 mesecev (npr. 7. mesec) pa 100 %.
• inflammation of the nerves (neuritis) 
• vnetje živcev (nevritis),
• disease of the nerves of the eyes (optic neuritis) 
• bolezen vidnega živca (optični nevritis),
• swelling or infection of the brain (encephalitis) 
• otekanje ali okužba možganov (encefalitis),
The vaccine will not prevent infection caused by other agents such as hepatitis C and hepatitis E and other pathogens known to infect the liver. 
Cepivo ne bo preprečilo okužb z drugimi povzročitelji, kot sta virus hepatitisa C in virus hepatitisa E,
• immediate injection site pain, stinging and burning feeling 
• takojšnja bolečina na mestu vboda, občutek zbadanja in pekoč občutek,
If you are taking medicines that affect your body's immune response, you can still have Ambirix if this is thought to be necessary. 
Če jemljete zdravila, ki vplivajo na imunski odziv, lahko kljub temu prejmete cepivo Ambirix, če se zdi to potrebno, vendar cepivo morda ne bo delovalo popolnoma.
Following widespread use of either GlaxoSmithKline's combined hepatitis A and hepatitis B vaccines or the monovalent hepatitis A and/or hepatitis B vaccines, the following adverse reactions have additionally been reported. 
Po široki uporabi kombiniranih cepiv družbe GlaxoSmithKline proti hepatitisu A in hepatitisu B ali njenih monovalentnih cepiv proti hepatitisu A in/ali hepatitisu B so bili dodatno opisani naslednji neželeni učinki.
• Hepatitis A: Infection with the hepatitis A virus may cause the liver to become swollen (inflamed). 
• Hepatitis A: Okužba z virusom hepatitisa A lahko povzroči oteklino jeter (vnetje).
Blood and lymphatic system disorders Thrombocytopenic purpura, thrombocytopenia 
Bolezni krvi in limfatičnega sistema Trombocitopenična purpura, trombocitopenija.
Infections and infestations Meningitis 
Infekcijske in parazitske bolezni Meningitis.
A dose of 1.0 ml is recommended for subjects from 1 year up to and including 15 years of age. 
Priporočen odmerek za od 1 do vključno 15 let stare osebe je 1,0 ml.
Concomitant vaccines should always be administered at separate injection sites and preferably into different limbs. 
V primeru sočasnega dajanja je cepiva potrebno vedno aplicirati na ločena mesta, najboljše v drugo okončino.
After a few days they may be very tired, and have dark urine, pale faeces, yellowish skin or eyes (jaundice). 
Po nekaj dneh so lahko zelo utrujeni, imajo temen urin, svetlo blato,
LIST OF EXCIPIENTS Sodium chloride Water for injections 
natrijev klorid voda za injiciranje
Talk to your doctor, nurse or pharmacist before having Ambirix if: 
Posvetujte se z zdravnikom, medicinsko sestro ali farmacevtom, preden se cepite s cepivom Ambirix,
In subjects aged 12-15 years at primary vaccination the anti-HAV and anti-HBs antibody concentrations were comparable between groups that had received Ambirix or a 3-dose regimen of the combined vaccine (content as described above). 
Koncentracije protiteles anti-HAV in anti-HBs so bile pri osebah, starih ob prvem cepljenju od 12-15 let, primerljive s skupino, ki je prejela cepivo Ambirix, in skupino, ki je prejela 3 odmerke kombiniranega cepiva (vsebnost je opisana zgoraj).
Nervous system disorders Syncope or vasovagal responses to injection, localised hypoaesthesia 
Sinkopa ali vazovagalni odziv na injekcijo, omejena hipestezija.
If you are not sure, talk to your doctor, nurse or pharmacist before having Ambirix. 
Če niste prepričani, se pogovorite z zdravnikom, medicinsko sestro ali farmacevtom, preden se cepite s cepivom Ambirix.
Pack sizes of 1 and 10 pre-filled syringes with or without needles and pack size of 50 pre-filled syringes without needles. 
Velikost pakiranja: po 1 in 10 napolnjenih injekcijskih brizg z injekcijskimi iglami ali brez njih ter po 50 napolnjenih injekcijskih brizg brez injekcijskih igel.
It is found in body fluids such as blood, semen, vaginal secretions, or saliva (spit). 
Virus se nahaja v telesnih tekočinah, kot so kri, sperma, nožnični izločki ali slina (izpljunki).
If any of the above apply (or you are not sure), talk to your doctor, nurse or pharmacist before having Ambirix. 
Če za vas velja karkoli od zgoraj naštetega (oziroma ste negotovi), se posvetujte z zdravnikom, medicinsko sestro ali farmacevtom pred cepljenjem s cepivom Ambirix.
This leaflet was last revised in {month YYYY} 
Navodilo je bilo nazadnje revidirano dne Drugi viri informacij
1-5 yrs old 
1-5 let
Carriers are also at risk of serious liver problems, such as scarring (cirrhosis) or liver cancer. 
Pri klicenoscih virusa hepatitisa B obstaja tveganje za resne težave z jetri, kot sta brazgotinjenje jeter (ciroza) in rak jeter.
When the first dose of Ambirix was administered concomitantly with a booster dose of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTPa-IPV+Hib) or with the first dose of a combined Measles-Mumps-Rubella vaccine in the second year of life, immune responses to all antigens were satisfactory. 
Če se je prvi odmerek cepiva Ambirix dal sočasno z obnovitvenim odmerkom mešanega cepiva proti davici, tetanusu, oslovskemu kašlju - acelularno, otroški ohromelosti - inaktivirano in Haemophilusu influenzae tipa b (DTPa-IPV+Hib) ali s prvim odmerkom mešanega cepiva proti ošpicam, mumpsu in rdečkam v drugem letu življenja, so bili imunski odzivi na vse antigene zadovoljivi.
• inflammation of some blood vessels (vasculitis) 
• vnetje nekaterih žil (vaskulitis),
• flu-like symptoms, such as high temperature, sore throat, runny nose, cough and chills 
• gripi podobni simptomi, npr. zvišana telesna temperatura, vnetje žrela, izcedek iz nosu,
What you need to know before you receive Ambirix 
Kaj morate vedeti, preden boste prejeli cepivo Ambirix Cepiva Ambirix ne smete prejeti:
Seropositivity rates for anti-HBs antibodies were 74.2% one month after the first dose and 100% after the second dose given at month 6 (i.e. month 7). 
En mesec po prejemu prvega odmerka je bil odstotek seropozitivnosti za protitelesa anti-HBs 74,2 %, po prejemu drugega odmerka čez 6 mesecev (npr. 7. mesec) pa 100 %.
• reduction in blood platelets, which increases risk of bleeding or bruising (thrombocytopenia), 
• zmanjšanje števila krvnih ploščic, ki poveča tveganje za krvavitve ali podplutbe (trombocitopenija), vijoličaste ali rdečerjave pike, vidne skozi kožo (trombocitopenična purpura).
At 6 years following the initiation of a 0, 6 month or a 0, 12 month schedule of Ambirix in children aged 12-15 years all subjects followed up retained ≥15 mIU/ml anti-HAV antibody. 
6 let po cepljenju otrok, starih od 12 do 15 let, s cepivom Ambirix po shemi 0., 6. mesec ali 0., 12. mesec so vse osebe ohranile ≥15 mi.e./ml protiteles anti-HAV.
General disorders and administration site conditions Very common: fatigue, pain and redness at the injection site Common: fever, swelling at the injection site 
Splošne težave in spremembe na mestu aplikacije Zelo pogosti: utrujenost, bolečina in pordelost na mestu injiciranja.
Immune system disorders Allergic reactions including anaphylactic and anaphylactoid reactions 
Alergijske reakcije, vključno z anafilaktično in anafilaktoidno reakcijo.
Skin and subcutaneous tissue disorders Rare: pruritus, rash 
Bolezni kože in podkožja Redki: srbenje, izpuščaj.
Side effects that occurred during routine use of Ambirix were as follows: 
Med rutinsko uporabo cepiva Ambirix so se pojavili naslednji neželeni učinki:
Infections and infestations Uncommon: upper respiratory tract infection 
Občasni: okužba zgornjih dihal.
In addition, the following adverse reactions were reported during clinical trials with GlaxoSmithKline's other combined hepatitis A and hepatitis B vaccines (given as a 3 or 4 dose schedule) 
Poleg tega so bile med kliničnimi preskušanji drugih kombiniranih cepiv družbe GlaxoSmithKline proti hepatitisu A in hepatitisu B (uporabljenih v 3 ali 4 odmerkih) opisani naslednji neželeni učinki.
The following adverse reactions were reported during clinical trials with Ambirix. 
Naslednji neželeni učinki so se pojavili pri kliničnih preskušanjih s cepivom Ambirix:
How to store Ambirix 
Shranjevanje cepiva Ambirix
month schedules were 84.8% and 92.9%, respectively. 
92,9 % pri drugih.
• swollen glands in the neck, armpit or groin (lymphadenopathy) 
• otekle bezgavke na vratu, v pazduhah ali dimljah (limfadenopatija),
If rapid protection against hepatitis B is required, the standard three dose regimen of the combined vaccine containing 360 ELISA Units of formalin inactivated hepatitis A virus and 10 micrograms of recombinant hepatitis B surface antigen is recommended. 
V primeru potrebe po hitri zaščiti pred hepatitisom B je priporočljiva standardna shema treh odmerkov kombiniranega cepiva z vsebnostjo 360 ELISA enot s formalinom inaktiviranega virusa hepatitisa A in 10 mikrogramov rekombinantnega površinskega antigena virusa hepatitisa B. V vmesnem obdobju med prejemom drugega in tretjega odmerka kombiniranega cepiva bo tako zaščiten večji odstotek oseb, kot je po enem samem odmerku cepiva Ambirix.
United Kingdom GlaxoSmithKline UK Tel: +44 (0)800 221 441 customercontactuk@gsk.com 
United Kingdom GlaxoSmithKline UK Tel: +44 (0)800 221 441
In a comparative clinical trial conducted among subjects aged from 12 years up to and including 15 years of age, 142 received two doses of Ambirix and 147 received the standard three-dose combined vaccine. 
15 let, jih je 142 prejelo dva odmerka cepiva Ambirix, 147 pa jih je prejelo standardno cepivo s tremi odmerki.
Ambirix is indicated in non-immune children and adolescents from 1 year up to and including 15 years of age for protection against hepatitis A and hepatitis B infection. 
Cepivo Ambirix je indicirano za zaščito pred okužbo z virusom hepatitisa A in okužbo z virusom hepatitisa B pri neimuniziranih otrocih in mladostnikih od 1 do vključno 15 let starosti.
When Ambirix was administered concomitantly with, but as a separate injection to a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTPa-IPV+Hib) or with a combined Measles-Mumps-Rubella vaccine in the second year of life, immune responses to all antigens were satisfactory (see section 5.1). 
oslovskemu kašlju - acelularno, otroški ohromelosti - inaktivirano in Haemophilusu influenzae tipa b (DTPa-IPV+Hib) ali mešanega cepiva proti ošpicam, mumpsu in rdečkam v drugem letu življenja, je bil imunski odziv na vse antigene zadovoljiv (glejte poglavje 5.1).
Ambirix should not be given if any of the above apply. 
S cepivom Ambirix se ne smete cepiti, če velja karkoli od zgoraj naštetega.
Skin and subcutaneous tissue disorders Erythema multiforme, lichen planus 
Multiformni eritem, lichen planus.
2D barcode carrying the unique identifier included. 
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA Vsebuje dvodimenzionalno črtno kodo z edinstveno oznak 18.
HAB vaccine 
Žilne bolezni
For the 289 subjects evaluable for immunogenicity, seroprotection rates (SP in the table below) against hepatitis B were significantly higher at months 2 and 6 with the three-dose vaccine than with Ambirix. 
Slednje je vsebovalo 360 ELISA enot s formalinom inaktiviranega virusa hepatitisa A in 10 mikrogramov rekombinantnega površinskega antigena virusa hepatitisa B. Pri 289 osebah, pri katerih je bila ovrednotena imunogenost, je bil v 2. in 6. mesecu odstotek serozaščite (SP v spodnji tabeli) proti hepatitisu B signifikantno višji po cepljenju s tremi odmerki cepiva kot pa po cepljenju s cepivom Ambirix.
Very common (These may occur with more than 1 in 10 doses of the vaccine) : 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 odmerkov cepiva):
• fits or seizures 
Bolezni kože in podkožja
GlaxoSmithKline AS Tlf: + 47 22 70 20 00 firmapost@gsk.no 
Tlf: + 47 22 70 20 00 firmapost@gsk.no
• numbness or weakness of the arms and legs (neuropathy) 
• omrtvičenost ali šibkost rok in nog (nevropatija),
Musculoskeletal and connective tissue disorders Arthritis, muscular weakness 
Artritis, mišična šibkost.
• Clinical trial data 
• Podatki iz kliničnih preskušanj
General disorders and administration site conditions Immediate injection site pain, stinging and burning sensation 
Splošne težave in spremembe na mestu aplikacije Takojšnja bolečina na mestu vboda, občutek zbadanja in pekoč občutek.
Blood and lymphatic system disorders Rare: lymphadenopathy 
Bolezni krvi in limfatičnega sistema
Vaccine group 
Skupina glede na cepljenje
Hepatitis A virus (inactivated)1,2 
1 odmerek (1 ml): Virus hepatitisa A (inaktivirani)1,2
No data on concomitant administration of Ambirix with specific hepatitis A immunoglobulin or hepatitis B immunoglobulin have been generated. 
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Podatki o sočasnem dajanju cepiva Ambirix in specifičnih imunoglobulinov proti hepatitisu A ali imunoglobulinov proti hepatitisu B niso bili pridobljeni.
Contents of the pack and other information 
Shranjevanje cepiva Ambirix Vsebina pakiranja in dodatne informacije
It is possible that subjects may be in the incubation period of a hepatitis A or hepatitis B infection at the time of vaccination. 
Možno je, da so osebe v času cepljenja že v inkubacijskem obdobju okužbe s hepatitisom A ali hepatitisom B. Ni znano, če v takšnih primerih cepivo Ambirix preprečuje hepatitis A in hepatitis B.
Cases of overdose with GlaxoSmithKline's combined hepatitis A and hepatitis B vaccine have been reported during post-marketing surveillance. 
Med obdobjem postmarketinškega spremljanja so bili opisani primeri prevelikega odmerjanja kombiniranega cepiva proti hepatitisu A in hepatitisu B družbe GlaxoSmithKline.
Hepatobiliary disorders Abnormal liver function tests 
Nenormalni testi jetrne funkcije.